[Osteoprotegerin is a new marker of cardiovascular diseases].
Osteoprotegerin (OPG) is a glycoprotein that is a representative of the tumor necrosis factor-Î± receptor superfamily.
Information about the possible role of OPG in the development of cardiovascular diseases has begun to appear in the literature in recent years.
This review discusses the role of increasing the level of OPG in the development and progression of atherosclerosis and as a consequence of coronary heart disease and chronic heart failure.
